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Abstract
Monoamine oxidase (MAO) A, the major enzyme catalyzing the oxidative degradation of
serotonin (5-hydroxytryptamine, 5-HT), plays a key role in emotional regulation. In humans and
mice, MAO-A deficiency results in high 5-HT levels, antisocial, aggressive, and perseverative
behaviors. We previously showed that the elevation in brain 5-HT levels in MAO-A knockout
(KO) mice is particularly marked during the first two weeks of postnatal life. Building on this
finding, we hypothesized that the reduction of 5-HT levels during these early stages may lead to
enduring attenuations of the aggression and other behavioral aberrances observed in MAO-A KO
mice. To test this possibility, MAO-A KO mice were treated with daily injections of a 5-HT
synthesis blocker, the tryptophan hydroxylase inhibitor p-chloro-phenylalanine (pCPA, 300 mg/
kg/day, IP), from postnatal day 1 through 7. As expected, this regimen significantly reduced 5-HT
forebrain levels in MAO-A KO pups. These neurochemical changes persisted throughout
adulthood, and resulted in significant reductions in marble-burying behavior, as well as increases
in spontaneous alternations within a T-maze. Conversely, pCPA-treated MAO-A KO mice did not
exhibit significant changes in anxiety-like behaviors in a novel open-field and elevated plus-maze;
furthermore, this regimen did not modify their social deficits, aggressive behaviors and
impairments in tactile sensitivity. Treatment with pCPA from postnatal day 8 through 14 elicited
similar, yet milder, behavioral effects on marble-burying behavior. These results suggest that early
developmental enhancements in 5-HT levels have long-term effects on the modulation of
behavioral flexibility associated with MAO-A deficiency.
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Serotonin (5-hydroxytryptamine, 5-HT) plays a fundamental role in the orchestration of
emotional reactivity and in the pathophysiology of numerous mental disorders, ranging from
anxiety to pathological aggression (Baldwin and Rudge, 1995; Lucki, 1998; Olivier, 2004).
One of the most important mechanisms for the regulation of 5-HT neurotransmission is its
metabolism by oxidative deamination, primarily catalyzed by monoamine oxidase (MAO) A
(Bortolato et al., 2008; Bortolato et al., 2009). This mitochondrial membrane-bound
enzyme, which is encoded by a gene located on the X-chromosome in all vertebrate species
(Bortolato et al., 2008), also serves the degradation of other monoamine transmitters, such
as norepinephrine (NE) and dopamine (DA) (Shih et al., 1999; Bortolato et al., 2010). The
bulk of evidence indicates that low MAO-A brain activity may be a viable marker for the
severity of antisocial traits (Alia-Klein et al., 2008). In addition, several studies have
documented that MAOA allelic variants associated with low catalytic activity predispose
maltreated and abused boys to develop antisocial and aggressive traits (Caspi et al., 2002;
Kim-Cohen et al., 2006; Fergusson et al., 2011).
In humans, a nonsense mutation of the MAOA gene results in Brunner syndrome, an X-
linked condition characterized by antisocial and disruptive traits, violent aggression in
response to sudden stressors, repetitive behaviors and mild cognitive impairments (Brunner
et al., 1993a; Brunner et al., 1993b). Consistently, MAO-A knockout (KO) mice display
marked aggression, in association with other phenotypic alterations, including social and
communication deficits, perseverative and neophobic-like responses, sensory disturbances,
as well as disrupted barrel fields in the somatosensory cortex (Cases et al., 1995; Kim et al.,
1997; Godar et al., 2011; Bortolato et al., 2012a). These aberrances are accompanied by
elevated 5-HT brain concentrations, particularly during the first two postnatal weeks of life
(Cases et al., 1995).
Several findings suggest that the phenotypic abnormalities associated with MAO-A
deficiency may depend on their high 5-HT brain levels during early postnatal stages: first,
inhibition of 5-HT synthesis with the tryptophan hydroxylase inhibitor p-chloro-
phenylalanine (pCPA) during the first postnatal weeks was shown to normalize barrel field
morphogenesis (Cases et al., 1996); second, the aberrant phenotypes in MAO-A KO mice
are rescued by the reinstatement of this enzyme in the forebrain at birth (Chen et al., 2007);
third, perinatal administration of MAO-A blockers induces long-term aggressive responses
and other behavioral changes (Whitaker-Azmitia et al., 1994; Mejia et al., 2002).
In contrast with this background, the long-term impact of early pCPA administration on the
aggression and other behavioral impairments of adult MAO-A KO mice has not yet been
examined. Thus, in the present study we examined whether pCPA administration in the first
two postnatal weeks of life may affect aggression and other behavioral phenotypes of MAO-
A KO mice, including social deficits, perseverative and alterations of anxiety-like responses.
In addition, we verified whether this treatment may induce specific alterations of NMDA
glutamate receptor subunit composition, in view of our recent discovery that alterations in
this receptor are likely to contribute to the aggression in MAO-A KO mice (Bortolato et al.,
2012b).
2. Materials and methods
2.1 Subjects and treatment schedule
We used experimentally naïve male 129S6 MAO-AA863T KO and wild-type (WT) mice,
generated and genotyped as previously described (Scott et al, 2008). Since MAO A is
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located on the X-chromosome, mice were bred from WT males crossed with heterozygous
MAO-A KO females and litters were culled to 6-8 pups. Animals were injected with either
pCPA (300 mg/kg/day, i.p., q.d.; Sigma-Aldrich, St. Louis, MO, USA) or saline solution
during the first or the second postnatal week (Fig.1). Intraperitoneal injections were
performed at an injection volume of 10 ml/kg, using an injector attached to a micro-syringe.
In addition, a group of mice was left untreated to control for the potentially stressful
influence of early daily injections. In preliminary studies, we observed that the stress
associated with early tattooing or permanent marking led to alterations of maternal behavior
(including cannibalism) and/or enduring alterations of stress response. To avoid these
potential confounds, all male offspring of each mother (both WT and MAO-A KO
littermates) was subjected to the same treatment conditions. Litter effects were minimized
by using animals from at least 8 litters for each treatment group for P1-P7 injections and 4
litters for each treatment group for P8-P14 injections. No more than 2 homogenotypic male
littermates (randomly selected) in each group were used. Once weaned, male mice were
group-housed with other conspecifics from other litters and treatment groups, and received
ad libitum access to food and water, in facilities maintained at 22°C on a 12 h: 12 h light/
dark cycle.
Mice were isolated on postnatal day 80 (P80) and tested between P90 and P120 (adulthood).
This isolation regimen was selected to minimize the potentially detrimental behavioral
outcomes of aggressive interactions with MAO-A KO male mice (which display
spontaneous aggression towards cage mates); in addition, these conditions are optimal to
elicit mild levels of aggressiveness in WT males during the resident-intruder test.
All in vivo experimental procedures were in compliance with the National Institute of Health
guidelines and approved by the Animal Use Committees of the University of Southern
California and University of Cagliari.
2.2 Neurochemical analyses
For biochemical analyses, male mice were deeply anesthetized with isoflurane and promptly
decapitated. Brains were removed within approximately 30 s after decapitation, and
forebrain regions were freshly dissected as described by Spijker (2011). Prefrontal cortices
were obtained from adult brains by coronal sections (Spijker, 2011). Whole pup forebrains
were harvested, to obtain sufficient biological material for further analyses.
2.2.1 HPLC determination of monoamine levels—Forebrain samples were kept in
dry ice and rapidly homogenized with an ultrasonic tissue disrupter (Sonoplus HD60,
Bandelin, Germany), in a solution containing 0.1 M trichloroacetic acid, 10 mM sodium
acetate, and 0.1 mM EDTA; 1 μM isoproterenol was used as an internal standard. The
homogenates were centrifuged, and the supernatants were used for high performance liquid
chromatography (HPLC) analysis. The mobile phase was the same as the homogenization
buffer with 7% methanol for detection of 5-HT. The mobile phase was filtered and
deaerated, and the pump speed (Shimadzu LC-6A liquid chromatograph, Columbia, MD,
USA) was 1.5 ml/min. The reverse-phase column used was a Rexchrom S50100-ODS C18
column with a length of 25 cm and an internal diameter of 4.6 mm. The compounds were
measured at +0.7 V using a Shimadzu L-ECD-6A electrochemical detector.
2.2.2. Western blot analyses of NMDA receptor subunits—Prefrontal cortex
samples were homogenized in ice cold buffer (50 mM HEPES, pH 7.4, 40 mM β-glycerol
phosphate, 1mM sodium orthovanadate, 50mM Sodium Fluoride, 2mM EDTA, 20 μM
ZnCl2, 1% Sodium deoxycholate) and protease inhibitors. The homogenates were
centrifuged at 75,000 × g for 30 min at 4°C and supernatants used for wester n blotting
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assays. Equal amounts of protein from each sample (20 μg) were used in standard western-
blot assays for NR1 (Cell Signaling, Danvers, MA, USA), NR2B and NR2A (NeuroMab,
Davis, CA, USA). Blots were developed by chemiluminescence detection in a Kodak
4000MM imaging station. Bands were quantified in arbitrary units and normalized for
protein concentrations using β-actin as loading control.
2.3. Behavioral testing
Environmental light and sound levels were maintained at 10 lux and 70 dB for all behavioral
tests unless otherwise indicated. Testing was performed between 10 am and 3 pm with lights
on at 6 am in the listed sequence below. Experiments on animals injected during the first and
second postnatal weeks were performed and analyzed separately. All behaviors were video-
recorded and analyzed by trained observers, who were blind to the genotype and treatment
of the mice. To reduce carryover effects due to stress ensuing repeated testing, each animal
was used for no more than 3 different tests (with a time interval of at least 1 week between
two consecutive tests) and the order of testing was randomized (with the exception of social
interaction and resident-intruder aggression tests, which were always performed at the end
of behavioral batteries).
2.3.1. Open field—Analysis of open-field behaviors was performed to assess locomotor
and exploratory responses, as well as anxiety-related reactivity. Testing was performed in a
Plexiglas square grey arena (40 × 40 cm) surrounded by 4 black walls (40 cm high), based
on a modified version of the protocol detailed elsewhere (Bortolato et al, 2011). On the
floor, two zones of equivalent areas were defined: a central square quadrant and a concentric
peripheral frame. Mice (n = 11-13 mice per group) were placed in the central zone and their
behavior was monitored for 5 min using Ethovision behavioral tracking software (Noldus
Instruments, Wageningen, The Netherlands). Behavioral measures included the total
locomotor activity, time spent in the center, and the percent locomotor activity in the center
(calculated as the distance traveled in the center over the total distance traveled).
2.3.2. Elevated plus-maze—The elevated plus-maze protocol was used to measure
contextual anxiety and performed as previously described (Pellow et al, 1985; Bortolato et
al, 2009). Briefly, the apparatus was comprised of two open arms and two closed arms in
black Plexiglas with a light grey floor, which extended from a central platform. Mice (n=
11-13 per group) were placed individually on the central platform, facing an open arm, and
allowed to explore the maze for 5 min. An arm entry was counted only when all four paws
were inside the arm. Behavioral measures included the number of entries and time spent in
each compartment of the maze, as well as the number of stretch-attend postures and head
dips (previously defined in Godar et al, 2011).
2.3.3. Novel object exploration—Novel object exploration was tested to assess
exploratory responses and neophobia. The assay was conducted in the home cage to
maximize neophobic responses in MAO-A KO mice as previously detailed (Godar et al,
2011). Two novel black plastic cylinders (8-cm high; 3.5 cm diameter) were symmetrically
placed in the cage. Mice (n = 8-10 per group) were allowed to freely explore the objects and
environment for 15 min. Exploration was defined as sniffing or touching the object with the
snout, and measured as the frequency and total time spent exploring both objects; climbing
on the object was not considered exploration.
2.3.4. Marble burying—This paradigm was used to capture anxiety-driven perseveration.
Testing was performed in Makrolon cages containing 5 cm of sawdust, as previously
described (Bortolato et al, 2009). Mice (n = 11-13 per group) were individually placed in the
cage and their behavior was monitored for 30 min. Mice were removed and 20 glass marbles
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(1.5 cm in diameter) were placed on the sawdust at equal distances. The animal was then
reintroduced into the cage and its behavior was monitored for 30 additional min. The
number of buried marbles was counted; a marble was considered buried if at least two-thirds
of its surface area was covered in sawdust.
2.3.5. Spontaneous alternations in the T-maze—To ascertain the potential effect of
pCPA on perseverative responses, spontaneous alternations were tested in a T-maze, as
previously described (Bortolato et al, 2012). Briefly, each session consisted of eight
consecutive trials. In each trial, the mouse (n = 10-12 per group) was placed in the start
compartment of a T-maze. After 15 s, the door was lifted and the mouse was left free to
explore the two arms of the maze. As soon as the animal entered (with all four paws) one of
the two alternative arms (left or right), the door of that compartment was closed for 15 s to
confine the animal. The animal was removed between trials and the T-maze was quickly
cleaned and dried to remove any olfactory cue that may condition the performance in the
next trial. A trial was considered failed if the animal did not enter an arm within 120 s. Mice
that recorded two failures were eliminated from testing. The percentage of arm alternations
was analyzed for each mouse.
2.3.6. Social interaction—Mice were tested as described elsewhere (Bortolato et al,
2011). Mice (n = 9-10 per group) were placed into a neutral, unfamiliar Makrolon cage, with
foreign age- and weight-matched male WT conspecifics (from separate litters). Testing
sessions lasted 10 min and were scored for social behaviors, which consisted of the number
and overall duration of social exploratory approaches towards the conspecifc (defined as
investigative sniffing of the facial and anogenital areas of the conspecific).
2.3.7. Resident-intruder aggression—Testing was conducted as previously described
(Bortolato et al, 2011). To study aggression, animals were isolated at P80 for 14 days, a
duration that we have previously identified as optimal to establish aggression in MAO-A
KO males. Following a 30-min habituation period within the home cage in the experimental
room, mice (n = 12-14 per group) were exposed to age- and weight-matched WT males
(previously acclimated to the same room) from different litters, for 10 min. Measures
included the number and duration of fighting bouts.
2.3.8. Sticky-tape test—The sticky-tape test was carried out as described elsewhere
(Bortolato et al, 2012), to measure potential deficits in sensorimotor reflexes in MAO-A KO
mice. Animals (n = 9-11 per group) were briefly restrained and a circular piece of tape (5
mm in diameter) was placed on the bottom of each forepaw. The time to remove each piece
of tape was recorded.
2.3.9. Hot plate—To assess the impact of pCPA on pain sensitivity, mice were tested on a
hot plate (IITC, Woodland Hills, CA, USA) as previously described (Bortolato et al, 2012).
Mice (n = 11-13 per group) were placed on the hot plate and the latency to lick their paws
was measured; a 20-s cut-off time was used to avoid potential tissue damage. The hot plate
was maintained at 52.5°C, as this temperature was shown to elicit a significant delay in paw-
licking latency in MAO-A KO mice (Bortolato et al, 2012).
2.4. Statistical analyses
Normality and homoscedasticity of data distribution were verified by using Kolmogorov-
Smirnov and Bartlett’s tests. Statistical analyses on parametric data were performed using
two-way ANOVAs, followed by Newman-Keuls test for post-hoc comparisons. Significance
threshold was set at 0.05. All statistical analyses were performed by STATISTICA 7
(Statsoft, Tulsa, OK).
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3.1.1. Forebrain 5-HT levels in 8-day old mice—We ascertained that pCPA
administration resulted in the normalization of forebrain 5-HT levels in MAO-A KO pups at
postnatal day 8. We found that this treatment in the first week led to a reduction in 5-HT
concentrations across both genotypes (Table 1). Significant main effects of genotype [F(1,
30) = 114.58; P<0.001, ANOVA] and treatment [F(2, 30)= 49.10; P<0.001, ANOVA] were
detected. In addition, a significant genotype × treatment interaction was found [F(2, 30) =
17.18; P<0.001, ANOVA]. Post-hoc analyses revealed that untreated and saline-injected
MAO-A KO pups had higher 5-HT forebrain concentrations than their WT counterparts
(P<0.001 for both comparisons). In WT mice, pCPA administration significantly reduced 5-
HT levels in comparison with both untreated (P<0.05) and saline-injected (P<0.05)
counterparts. Similarly, pCPA treatment produced a marked decrement in forebrain 5-HT
concentrations in MAO-A KO mice, as compared with both untreated and saline-treated
(Ps<0.001 for both comparisons) animals.
3.1.2. Prefrontal 5-HT levels in adult mice—Early pCPA treatment resulted in long-
term reductions in 5-HT levels also in the prefrontal cortex of adult (90-day old) WT and
MAO A-KO mice (Table 1). Indeed, ANOVA identified significant main effects of
genotype [F(1,42)=20.81; P<0.001] and treatment [F(2,42)=53.30; P<0.001], as well as a
significant genotype × treatment interaction [F(2,42)=7.42; P<0.01]. Post-hoc comparisons
revealed that this latter effect was due to significant differences between untreated WT and
MAO A KO mice (P<0.01), saline-treated WT and MAO A KO mice (P<0.001), as well as
pCPA-treated mice and their untreated or saline-injected counterparts (Ps<0.01 for all
comparisons; Newman-Keuls).
3.1.3. Prefrontal NMDA receptor (NMDAR) subunit expression in adult mice—
To verify whether pCPA treatment may affect NMDAR subunit composition, we measured
NR1, NR2A and NR2B levels in the prefrontal cortex of pCPA-treated WT and MAO-A KO
mice, as compared with their saline-injected counterparts. As shown in Table 2, we found
that NR1 [Main effect of genotype: F(1,15)= 0.51, NS] and NR2A [F(1,15)= 0.51, NS]
subunits were not altered in MAO-A KO mice; conversely, NR2B subunits were
significantly increased [F(1,15)= 22.84, P<0.001] in MAO-A KO mice, as compared to WT
counterparts. Notably, early postnatal pCPA administration did not affect the expression of
any of these subunits [genotype × treatment interactions: NR1: F(1, 15) = 0.51, NS; NR2A:
F(1, 15)=0.06, NS; NR2B: F(1, 15) = 0.07, NS].
3.2. Behavioral testing
3.2.1. Open field—The analysis of overall locomotor activity in a novel open field (Fig.
2A) revealed a significant main effect of genotype [F(1, 53)=12.82; P<0.001], but not
treatment; furthermore, no significant genotype × treatment interactions were found,
signifying that the hypolocomotion of MAO-A KO mice was not affected by early pCPA or
saline administration. The analysis of the time spent in the center quadrant of the open field
(Fig.2B) revealed significant main effects of both genotype [F(1, 54) = 4.14; P<0.05] and
treatment [F(2, 54) = 5.53; P<0.01], but no interactions between the two factors. Similarly,
the analysis of percent locomotor activity in the center (Fig. 2C) disclosed a statistical trend
for a main effect of genotype [F(1, 54) = 3.91; P<0.06] and a significant effect for treatment
[F(2, 54) = 3.82; P<0.05], but no genotype × treatment interactions.
3.2.2. Elevated plus-maze—In parallel with our findings in the open field, MAO-A KO
mice exhibited a reduced number of total entries (Fig.3A) [Main effect of genotype: F(1, 64)
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= 6.10; P<0.05] in the elevated plus-maze. Although the analysis of the percent entries in the
open (Fig.3B) and closed (Fig.3E) arms revealed significant genotype × treatment
interactions [%open entries: F(2, 64) = 3.74; P<0.05; %closed entries: F(2, 64) = 3.18;
P<0.05], post-hoc comparisons did not identify any significant changes between any
genotype × treatment groups, but only a statistical trend (P<0.10) for an increase in open
entries by MAO-A KO mice. Early pCPA administration was found to significantly increase
the time spent by MAO-A KO mice in the open arms (Fig.3C) [genotype × treatment
interaction: F(2, 64) = 5.04; P<0.01]. This effect was found to depend on a significant
difference (P<0.05) between pCPA- and saline-treated MAO-A KO mice. Conversely, no
significant difference was found between treatment groups of WT mice; furthermore, no
differences were found between WT and MAO-A KO mice with respect to any treatment
condition. Treatment with pCPA did not significantly affect the time spent in the central
platform (Fig.3D) [F(2, 64) = 0.12; NS] or in the closed arms (Fig.3F) [F(2, 64) = 2.06; NS].
As previously described (Godar et al, 2011), MAO-A KO mice also exhibited reductions in
stretch-attend postures (Fig. 3G) [F(1,64)=8.78; P<0.01; Main effect of genotype] and head
dips (Fig. 3H) [F(1,64)=8.41; P<0.01; Main effect of genotype] compared to WT mice.
Nevertheless, these effects were not significantly affected by pCPA treatment, as revealed
by the lack of significant treatment × genotype interaction for either parameter [stretch-
attend postures: F(2, 64) = 0.15; NS; head dips: F(2, 64) = 0.46; NS]. Similar to the open
field, MAO-A KO animals showed a significant reduction in the overall distance travelled in
the elevated plus maze [genotype: F(1, 64) = 6.10; P<0.05] (untreated WT: 1012.39 ± 81.35
cm; untreated MAO-A KO: 911.69 ± 66.48 cm; saline-treated WT: 1044.28 ± 59.88 cm;
saline-treated MAO-A KO: 887.88 ± 39.26 cm; pCPA-treated WT 1057.1 ± 40.25 cm;
pCPA-treated MAO-A KO: 948.73 ± 34.98 cm).
3.2.3. Novel object exploration—In comparison with WT mice, MAO-A KO
littermates engaged in fewer exploratory approaches towards novel objects (Fig.4A)
[genotype × treatment interaction: F(2,49) = 10.45; P<0.001]. Post-hoc comparisons
identified a significant difference (P<0.001) between untreated WT and MAO-A KO mice;
notably, this deficit was rescued by early pCPA treatment (Ps<0.05 for comparisons
between pCPA-treated MAO-A KO and either non-treated or saline-injected MAO-A KO
mice). Furthermore, both saline and pCPA treatment reduced the number of exploratory
approaches in WT mice (P<0.05 and P<0.01 for comparisons between saline-treated WT
and pCPA-treated WT vs untreated WT, respectively). All other comparisons between
genotype × treatment combinations did not reveal any significant difference. The analysis of
the sniffing duration (Fig.4B) confirmed that, while MAO-A KO mice explored the novel
objects for a significantly shorter time [genotype × treatment: F(2, 49) = 6.16; P<0.01;
P<0.01 for comparison between non-treated WT and MAO-A KO mice], this impairment
was fully prevented by pCPA administration (P<0.001). The analysis of the latencies to the
first exploratory approach (Fig. 4C) revealed significant main effects of the genotype
[F(1,49) = 12.78; P<0.001] and treatment [F(2,49) =5.27; P<0.01], as well as a significant
genotype × treatment interaction [F(2,49)=5.06, P<0.05]. Post-hoc comparisons revealed
that untreated MAO-A mutants had a significantly longer latency to explore novel objects
than WT counterparts (P<0.001). This latency was reduced by pCPA (P<0.001) and, to a
lesser extent, by saline treatment (P<0.05). Neither pCPA nor saline affected the same
parameters in WT mice. No significant difference among groups was found in locomotor
activity (data not shown).
3.2.4. Marble burying—As previously shown (Bortolato et al., 2012a), MAO-A KO mice
buried a greater number of marbles (Fig. 5A) [genotype × treatment: F(2, 57) = 8.75;
P<0.001] than WT littermates. This alteration was prevented by pCPA pre-treatment
(P<0.001 and P<0.01 for comparisons between pCPA-treated MAO-A KO vs non-treated
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and saline-injected MAO-A KO mice, respectively). In addition, the analysis of digging
duration showed a main effect of the genotype [F(1, 56) = 8.66; P<0.01], but no significant
genotype × treatment interaction (data not shown).
3.2.5. Spontaneous alternations in the T-maze—In line with our previous findings
(Bortolato et al., 2012a), we confirmed that MAO-A KO mice engaged in a significantly
lower percentage of spontaneous alternations (Fig. 5B) [genotype × treatment: F(2, 55) =
6.47; P<0.01; P<0.05 for comparison between non-treated WT and MAO-A KO mice]. This
effect, however, was rescued by early postnatal pCPA treatment (P<0.05 for comparisons
between pCPA-treated MAO-A KO and either non-treated or saline-injected MAO-A KO).
3.2.6. Social interaction and resident intruder task—MAO-A KO mice displayed a
significant reduction in the frequency (Fig.6A) [genotype: F(1, 39) = 29.46; P<0.001] and
duration (Fig.6B) [genotype: F(1, 40) = 27.34; P<0.001] of social exploration. In addition,
we found a significant treatment effect for the number of social approaches [F(2, 39) = 4.00;
P<0.05]. No significant interactions between genotype × treatment were found. The
locomotor activity was comparable across experimental groups (data not shown).
In the resident-intruder paradigm, MAO-A KO mice exhibited an increased number of
fighting bouts (Fig.6C) [Main effect of genotype: F(1, 50) = 49.50; P<0.001] and fighting
duration (Fig.6D) [Main effect of genotype: F(1, 50) = 30.57: P<0.001]. Moreover, a
significant treatment effect was detected for both parameters [bouts: treatment: F(2, 50) =
4.62; P<0.05 and duration: treatment: F(2, 50) = 4.00; P<0.05]. No significant differences in
genotype × treatment interactions were detected. All groups displayed equivalent locomotor
activities (data not shown).
3.2.7. Sticky-tape and hot plate tests—As previously shown (Bortolato et al., 2012a),
MAO-A KO mice exhibited a significant increase in the latency to remove sticky tape from
their forepaws (Fig.7A) [Main effect of genotype: F(1, 48) = 19.80; P<0.001]. In parallel,
MAO-A-deficient mice displayed an enhanced latency to lick their paws in response to the
exposure to a hot plate (Fig.7B) [Main effect of genotype: F(1, 60) = 6.02; P<0.05].
Notably, neither alteration was affected by pCPA treatment.
3.2.8. Effects of PCPA administration between P8 and P14—MAO-A mutants
treated with pCPA during the second postnatal week exhibited a significant reduction in
marble burying activity (Fig. 8A) [genotype × treatment: F(2, 32) = 4.10; P<0.05]. Post-hoc
analyses revealed that, while non-treated MAO-A KO mice buried significantly more
marbles than their non-treated WT counterparts, both saline (P<0.05) and pCPA (P<0.01)
markedly reduced this behavior. MAO-A-deficient animals showed a significant reduction
in exploratory approaches towards an unfamiliar object [main effect for genotype:
F(1,31)=13.77; P<0.001]. In addition, ANOVA detected a main effect of treatment
[F(2,31)=40.46; P<0.001] and a significant genotype × treatment interaction [F(2, 31) =
6.07; P<0.01] (Fig. 8B). Newman-Keuls test disclosed that untreated MAO-A KO mice
exhibited a significantly lower number of approaches in comparison with their WT
counterparts (P<0.001). In addition, saline and pCPA treatment significantly reduced the
same parameters in both WT (Ps<0.001 for both comparisons) and MAO-A KO mice
(Ps<0.05). The analysis of the duration of novel-object exploration disclosed a main
genotype effect [F(1,31)=6.73; P<0.05], but no significant genotype × treatment interactions
[F(1, 31) = 0.78; NS] (Fig. 8C).
The analysis of resident-intruder aggression revealed that MAO-A KO mice displayed a
significantly higher number of fighting episodes [Main effect of genotype: F(1,61)= 7.92;
p<0.01], but this difference was not affected by treatment [genotype × treatment: F(2, 61) =
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0.82; NS] (Fig. 8D). Overall fighting duration was also significantly greater in MAO-A
deficient animals [Main effect of genotype: F(1,60)= 8.85; p<0.01]. In addition, a significant
genotype × treatment interaction was found [F(2, 60) = 3.36; P<0.05]. Post-hoc analyses
showed that, while non-treated MAO-A KO mice engaged in significantly longer fighting
behaviors than their untreated WT counterparts (P<0.01), pCPA pretreatment increased this
parameter in WT (P<0.05), but not in MAO-A KO mice.
4. Discussion
The results of the present study showed that neonatal subchronic administration of pCPA,
the prototypical inhibitor of tryptophan hydroxylase, produced an enduring reduction of
brain 5-HT forebrain levels in WT and MAO-A KO mice, which lasted until adulthood.
These neurochemical changes led to a complex alteration of the abnormal phenotypes
associated with MAO A deficiency. On one hand, counterbalancing the early elevation of 5-
HT in MAO-A KO pups preserved the microcolumnar pattern in the barrel fields of the
somatosensory cortex (Cases et al., 1996), and led to a marked attenuation of their
perseverative and restricted responses, such as marble burying and lack of spontaneous
alternations in a T-maze (Bortolato et al., 2011; Bortolato et al., 2012a). On the other hand,
pCPA treatment from postnatal day 1 through 7 did not rescue the overtly aggressive
responses, social deficits and tactile alterations associated with MAO-A deficiency (Cases et
al., 1995; Scott et al., 2008; Bortolato and Shih, 2011; Bortolato et al., 2012a). In addition,
this treatment had only limited effects on behavioral responses related to multiple facets of
anxiety-like behavior. Indeed, in the open field, it did not result in significant changes in
thigmotactic behavior. Furthermore, in the elevated plus maze pCPA reduced the total
duration spent by MAO-A KO mice in the open arms, but produced only a statistical trend
for a reduction (rather than a significant effect) of the number of open-arm entries and failed
to ameliorate their reduction in stretch-attend postures and head dips. Finally, pCPA
increased the number of exploratory approaches performed by MAO-A KO mice towards
unfamiliar objects (Godar et al, 2011); however, this amelioration was not accompanied by a
selective effect of this drug (as compared to saline treatment) on either the overall
exploratory duration or the latency to the first approach to the novel object.
Our findings also documented that pCPA treatment during the second week of postnatal life
elicited a similar, albeit milder, attenuation of repetitive behaviors in MAO-A KO mice.
Collectively, these data strongly suggest that, in mice, the first (and, to a lesser extent, the
second) week of postnatal life is a critical stage for the role of MAO-A and 5-HT in brain
and behavioral development. These results also complement previous evidence reported by
our group and others, indicating that the abnormal phenotypes of MAO-A KO mice are
influenced by early developmental neurochemical imbalances. In fact, the perturbations
featured by these mutants were rescued by the genetic reinstatement of forebrain MAO-A
from postnatal day 1 onwards (Chen et al., 2007); in addition, pharmacological inhibition of
MAO-A in perinatal periods was shown to elicit long-term behavioral sequelae in rodents
(Boylan et al., 2000; Mejia et al., 2002).
We recently documented that MAO-A KO mice, in addition to their aggressive responses,
display a spectrum of behavioral alterations reminiscent of the key pathognomonic deficits
of autism-spectrum disorder (ASD), including social deficits, reduced communication and
repetitive, restricted behaviors (Bortolato et al., 2012a). An increased risk of social,
communicative, cognitive and neuromorphological impairments in ASD were also found in
subjects carrying polymorphic variants associated with low MAO-A catalytic activity
(Yirmiya et al., 2002; Cohen et al., 2003; Davis et al., 2008; Cohen et al., 2011). Our data
show that the perseverative and restricted behaviors in MAO-A KO mice may indeed be
supported by the high levels of 5-HT in early postnatal stages. This finding is consistent
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with the well-documented link between ASD and hyperserotonemia (Schain and Freedman,
1961; Ritvo et al., 1970; Anderson et al., 1987; Anderson et al., 1990; Mulder et al., 2004).
In particular, it is worth noting that recent studies have raised the possibility that high 5-HT
concentrations may result in stereotyped behavior and delays in age of social smile in ASD
patients (Sacco et al., 2010; for contrasting results see Kolevzon et al., 2010).
Previous reports documented that perinatal and neonatal pCPA treatment rescued early
neurological deficits and the dysmorphogenesis of the barrel cortex in MAO-A KO mice
(Cases et al., 1995; Cases et al., 1996). It has been clarified that the critical period for MAO-
A inhibition to result in impairments of the barrel cortex is limited to the first week of
postnatal life (Vitalis et al., 1998; Boylan et al., 2000). While our data cannot substantiate a
causal nexus between the restorative action of pCPA on corticogenesis and perseverative
behaviors, it is worth noting that the barrel fields afford a well-characterized template of
minicolumnar organization (Bruno et al., 2003), whose abnormalities have been posited to
underlie ASD pathophysiology (Casanova et al., 2002; Casanova et al., 2006). These
premises support the possibility that 5-HT input in perinatal periods may govern the
ontogenesis of brain circuits subserving behavioral plasticity; alterations of these processes
may lead to impaired cortical development and specific aberrances of information
processing.
Early pCPA treatment induced a permanent reduction of 5-HT levels in the prefrontal
cortices of WT and MAO-A KO mice. The bases of this phenomenon, albeit still unknown,
are likely reflect the modulatory influence of 5-HT on early neurogenesis, developmental
cellular migration and cytoarchitecture (Lauder and Krebs, 1978; Daubert and Condron,
2010). In particular, recent evidence indicates that 5-HT autoregulates the morphology and
innervation of its own system (Daubert and Condron, 2010); furthermore, the inhibition of
5-HT synthesis by pCPA at different developmental stages has been shown to affect cortical
connectivity and development (Chen et al., 1994; Vitalis et al., 2007). Thus, it is possible
that early treatment with the tryptophan hydroxylase inhibitor may cause persistent
reductions and/or damages in 5-HTergic fibers in the prefrontal cortex.
Irrespective of the mechanisms accounting for the enduring reduction in prefrontal 5-HT
content in pCPA-treated mice, this alteration may account for some of our behavioral
findings, such as the lack of ameliorative effects of this regimen on the social deficits and
aggression displayed by adult MAO-A KO mice. In fact, most studies have reported a
consistent link between 5-HT hypofunction and impulsive aggression in vertebrates
(Coccaro, 1989; Virkkunen and Linnoila 1993; Miczek et al., 2001). Deficits in prefrontal 5-
HT content are posited to be particular relevant for the control of aggression, insofar as they
may lead to an insufficient inhibition of affective triggers of impulsive aggression in limbic
areas (Amen et al., 1996). Accordingly, our tests showed that early pCPA treatment
selectively increased fighting duration in WT mice. Thus, it is possible that the persistent
reduction of 5-HT in the prefrontal cortex may intrinsically lead to an intrinsic enhancement
of aggression in adulthood, which could mask and override potential beneficial effects on
the early developmental bases of impulsive hostility in MAO-A KO mice. Similar views
may help explain the failure of early pCPA treatment to enhance social interaction and
modify most anxiety-related responses in these mutants.
Alternatively, our behavioral results may subtend a phenomenological dissociation between
aggression vulnerability and early elevation of 5-HT levels, which may challenge the
possibility of a primary role for this neurotransmitter in the high aggressiveness of MAO-A
KO mice. For example, it is possible that the high proclivity of MAO-A KO mice to engage
in antagonistic behaviors may depend on high levels of other MAO-A substrates, such as
DA and NE. Indeed, mice with null-allele mutations of DA transporter, NE transporter and
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catechol-O-methyl-transferase (COMT), which feature high levels of catecholamines, have
been shown to be significantly more aggressive than WT conspecifics (Gogos et al., 1998;
Haller et al., 2002; Rodriguiz et al., 2004; Volavka et al., 2004; Guo et al., 2007; Bedard et
al., 2010). Given that the elevation in catecholamine levels in MAO-A KO mice occurs
mainly after the second postnatal week of life (Cases et al., 1995), the potential contribution
of DA and NE to aggression may occur upon periadolescent stages, underscoring the
possibility of multiple critical developmental stages with respect to different neurochemical
substrates and behavioral outcomes.
We recently reported that MAO-A KO mice display changes in NMDAR subunit
composition in the prefrontal cortex. These alterations appear to play a critical role in the
aggressive responses enacted by MAO-A KO mice, as these behaviors are suppressed by
NMDAR antagonists (Bortolato et al, 2012b). Notably, the present results show that early
pCPA treatment did not alter the subunit expression of prefrontal NMDA receptors in MAO-
A KO mice, further supporting a critical role of these ionotropic channels in the
pathogenesis of aggression in these animals. We confirmed that the expression of NR2B, but
not NR1, was increased in the composition of NMDA receptors in the prefrontal cortex of
MAO-A KO mice. In contrast, no significant enhancement of NR2A was found, possibly
signifying a lesser involvement of this subunit in the behavioral aberrances in MAO-A KO
mice. Recent findings have documented that NR2B subunits in the prefrontal cortex are
required to regulate synaptic plasticity and working memory (Cui et al., 2011; Wang et al.,
2013), by interacting with calcium/calmodulin-dependent protein kinase II (CaMKII)
(Strack et al., 2000; Fink and Meyer, 2002).
Our behavioral assessments revealed that early saline treatment produced a number of
specific changes in both WT and MAO-A KO mice in comparison with their non-treated
counterparts. For example, we found that this treatment reduced the number of exploratory
approaches directed towards novel objects in WT mice. These data suggest that the stress
caused by daily punctures during the first postnatal week may result in enduring
enhancements in neophobia or reduction in novelty-seeking behavior, and are in alignment
with ample evidence indicating a link between early childhood traumas and the development
of anxiety-related symptoms in adult life (Heim and Nemeroff, 2001).
From a translational perspective, our findings temper the possibility that the early inhibition
of 5-HT synthesis may be a viable approach to prevent the aggressive and antisocial traits
associated with low brain MAO-A activity (Alia-Klein et al., 2008). Nevertheless, our
results cannot rule out that these behavioral problems may be efficiently countered by more
specific approaches aimed at the reduction of the early impact of 5-HT within select brain
regions and/or receptor subtypes. Ample evidence has shown that aggression is associated
with different changes in 5-HTergic activity across multiple areas within the aggression
circuitry (Summers et al., 2005). Moreover, different 5-HT receptor families mediate
opposite modulatory effects on distinctive aspects of aggression (Takahashi et al., 2011;
Bortolato et al., 2013); for example, while the genetic and pharmacological inactivation of
5-HT1B receptors increases the levels of aggression (Saudou et al., 1994), 5-HT2A receptor
antagonists exert anti-aggressive properties (Shih et al., 1999). Thus, the global reduction of
5-HT synthesis induced by pCPA may have actually reversed some imbalances related to
aggression in MAO-A KO mice, but these effects may be masked by alterations related to
impaired signaling of other 5-HT receptors or in specific subcortical regions. Notably, the
dysmorphogenic effect of excessive 5-HT on the barrel fields in MAO-A KO mice has been
shown to depend the overactivation of 5-HT1B receptors (Vitalis et al.,1998; Salichon et al.,
2001). Further studies will be necessary to evaluate the specific contribution of different 5-
HT receptor subtypes and brain regions to the aggressive phenotype of MAO-A KO mice.
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The results of the present study indicate that alterations in perseverative behaviors
associated with MAO-A deficiency are supported by high 5-HT levels in early
developmental stages. These findings support the existence of a sensitive period during
which 5-HT neurotransmission is likely to influence the formation of critical brain circuits
that govern the expression of anxiety-related and repetitive behaviors. Future research is
needed to unravel the complex set of neurobiological bases supporting aggressive features
and other behavioral aberrances caused by MAO-A deficiency.
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➢ Monoamine oxidase (MAO) A catalyzes the degradation of serotonin (5-HT).
➢ MAO A knockout (KO) mice display high 5-HT levels, aggression and
perseverative behaviors.
➢ MAO A KO pups were treated with the 5-HT synthesis inhibitor p-chloro-
phenylalanine (pCPA).
➢ Early pCPA treatment reduced perseveration, but not aggression in MAO A
KO mice
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Schematic representation of the experimental design for pCPA administration during the
first two postnatal weeks. Behavioral analyses were performed between postnatal day 90 and
postnatal day 120 (corresponding to adulthood).
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Effects of pCPA treatment from postnatal day 1 through 7 on open-field behaviors in adult
wild type (WT) and MAO-A KO mice. Values are represented as mean ± SEM. ^P<0.05;
^^^P<0.001 compared to WT mice (main effect of genotype). Main effects of treatment are
not indicated. For more details, see text.
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Effects of pCPA treatment from postnatal day 1 through 7 on elevated-plus maze behaviors
in adult wild type (WT) and MAO-A KO mice. Values are represented as mean ± SEM.
^P<0.05; ^^^P<0.001 compared to WT mice (main effect of genotype). †P<0.05 compared
to MAO-A KO mice treated with saline. For more details, see text.
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Effects of pCPA treatment from postnatal day 1 through 7 on the proclivity of adult wild
type (WT) and MAO-A KO mice to explore a novel object in their home cage. Values are
represented as mean ± SEM. *P<0.05; **P<0.01; ***P<0.001, compared to untreated WT
mice. #P<0.05; ###P<0.001, compared to untreated MAO-A-deficient mice; †P<0.05,
compared to saline-treated MAO-A KO mice. For more details, see text.
Bortolato et al. Page 20














Effects of pCPA treatment from postnatal day 1 through 7 on A) marble-burying behavior
and B) spontaneous alternations in a T-maze of adult wild type (WT) and MAO-A KO mice.
Values are represented as mean ± SEM. *P<0.05; ***P<0.001, compared to untreated WT
mice. #P<0.05; ###P<0.001, compared to untreated MAO-A-deficient
mice; †P<0.05; ††P<0.01 compared to saline-treated MAO-A KO mice. For more details, see
text.
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Effects of pCPA treatment from postnatal day 1 through 7 on A-B) social interaction and C-
D) resident-intruder aggression in adult wild type (WT) and MAO-A KO mice. Values are
represented as mean ± SEM. ^^^P<0.001 compared to WT mice (main effect of genotype).
For more details, see text.
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Effects of pCPA treatment from postnatal day 1 through 7 on the latencies to A) remove a
sticky tape from the paws and B) lick paws in the hot plate test of adult wild type (WT) and
MAO-A KO mice. Values are represented as mean ± SEM. ^P<0.05; ^^^P<0.001 compared
to WT mice (main effect of genotype). For more details, see text.
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Effects of pCPA treatment from postnatal day 8 through 14 on A) marble-burying behavior,
B-C) novel-object exploration; and D-E) resident-intruder responses of adult wild type (WT)
and MAO-A KO mice. Values are represented as mean ± SEM. ^P<0.05; ^^^P<0.001
compared to WT mice (main effect of genotype); *P<0.05; ***P<0.001, compared to
untreated WT mice. #P<0.05; ##P<0.01, compared to untreated MAO-A-deficient mice.
Main effects of treatment are not indicated. For more details, see text.
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Table 1
Effects of postnatal pCPA treatment from postnatal day 1 through 8 on 5-HT forebrain concentrations in 8-day
old (P8) and adult (90-day old; P90) mice. Values are displayed as mean ± SEM.
Table 1 P8 – FOREBRAIN(pg/mg of tissue)







































P<0.001, compared to saline-treated WT mice.
###
P<0.001 compared to untreated MAO A KO mice.
†††
P<0.001 compared to saline-treated MAOA KO mice.
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Table 2
Effects of postnatal pCPA treatment from postnatal day 1 through 7 on NMDA receptor subunit expression in
the prefrontal cortex of adult WT and MAO-A KO mice.

















Values represented as mean ± SEM.
^^^
P<0.001, compared to WT mice (main effect of genotype). For further details, see text.
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